Ephla Bio is building the future of personalized medicine by enabling therapies that target the 80% of disease-driving proteins hidden inside cells—targets conventional biologics can’t reach. Our AI-driven platform predicts patient-specific intracellular targets, unlocking personalized and semi-personalized therapeutics for diseases that currently lack treatment options. 

Our founding team combines deep expertise in machine learning, immunology, and therapeutic platform development from Stanford, Google Brain, Arsenal Bio, PACT Pharma, and the Francis Crick Institute. Supported by leading advisors across cancer immunology, antibody engineering, and computational biology, we’re building the pipeline to make personalized therapeutics scalable and affordable.

Ephla Bio, Inc.

Org chart

Teams

Offices

Ephla Bio, Inc.

Org chart

Teams

Offices

Related companies